Exelixis
EXEL
#1285
Rank
NZ$31.09 B
Marketcap
NZ$125.49
Share price
7.11%
Change (1 day)
83.46%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: NZ$117.31 NZD on 2026-10-28

Lowest end of day price: NZ$2.28 NZD on 2014-12-24

Stock price history of Exelixis from 2000 to 2026

Annual Stock Price Performance

Year Performance
2026 51.04%
2025 29.14%
2024 39.16%
2023 47.18%
2022-16.37%
2021-10.96%
2020 13.65%
2019-11.59%
2018-37.36%
2017 106.38%
2016 171.58%
2015 241.82%
2014-76.70%
2013 26.92%
2012-1.93%
2011-44.24%
2010 9.47%
2009 41.19%
2008-42.56%
2007-8.87%
2006-7.60%
2005 2.39%
2004 35.71%
2003-7.24%
2002-49.40%
2001 31.00%
2000-0.85%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
NZ$491.15 0.84%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$53.54 1.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$830.86 1.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$79.03 3.52%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$262.68 1.43%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$110.91 2.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$87.42 1.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$0.95-2.41%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$26.55 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA